Results 231 to 240 of about 86,839 (276)

Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome

open access: yes, 2020
Konig MF   +17 more
europepmc   +1 more source

Cytokine Storm Syndrome

open access: yesAnnual Review of Medicine, 2023
Cytokine storm syndrome (CSS), which is frequently fatal, has garnered increased attention with the ongoing coronavirus pandemic. A variety of hyperinflammatory conditions associated with multiorgan system failure can be lumped under the CSS umbrella, including familial hemophagocytic lymphohistiocytosis (HLH) and secondary HLH associated with ...
Randy Q Cron
exaly   +3 more sources

Cytokine Storm Syndromes in Pediatric Patients

The Journal of Allergy and Clinical Immunology: In Practice, 2023
Cytokine storm syndromes (CSS) represent a diverse group of disorders characterized by severe overactivation of the immune system. In the majority of patients, CSS arise from a combination of host factors, including genetic risk and predisposing conditions, and acute triggers such as infections.
Caroline Diorio   +2 more
openaire   +3 more sources

Etoposide Therapy of Cytokine Storm Syndromes

2019
Etoposide has revolutionized the treatment of primary as well as secondary hemophagocytic lymphohistiocytosis (HLH), and it is, together with corticosteroids, the most widely used therapy for HLH. In the early 1980s, long-term survival in primary HLH was
Jan-Inge, Henter   +1 more
openaire   +2 more sources

Bacteria-Associated Cytokine Storm Syndrome

2019
While viruses are considered the most common infectious triggers for cytokine storm syndromes (CSS), a growing list of bacterial pathogens, particularly intracellular organisms, have been frequently reported to be associated with this syndrome. Both familial and sporadic cases of CSS are often precipitated by acute infections.
Esraa M, Eloseily, Randy Q, Cron
openaire   +2 more sources

Cytokine storm syndrome in SARS-CoV-2: a review

Zeitschrift für Naturforschung C, 2021
Abstract After wreaking havoc on a global level with a total of 5,488,825 confirmed cases and 349,095 deaths as of May 2020, severe acute respiratory syndrome coronavirus 2 is truly living up to the expectations of a 21st-century pandemic.
Braira Wahid   +2 more
openaire   +2 more sources

Cytokines in Cytokine Storm Syndrome

2019
As the eponymous mediators of the cytokine storm syndrome, cytokines are a pleomorphic and diverse set of soluble molecules that activate or suppress immune functions in a wide variety of ways. The relevant cytokines for each CSS are likely a result of differing combinations of environmental triggers and host susceptibilities.
openaire   +2 more sources

Laboratory Features and Pathology of Cytokine Storm Syndromes

2019
The laboratory diagnosis of cytokine storm syndromes (CSSs), i.e., hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), is often challenging. The laboratory features using routinely available tests lack specificity, whereas confirmatory testing is available in only few laboratories in the United States.
Flavia G, Rosado, Purva, Gopal
openaire   +2 more sources

Criteria for Cytokine Storm Syndromes

In the past two decades, there has been a great deal of work aimed to devise diagnostic guidelines, classification criteria, and diagnostic scores for cytokine storm syndromes (CSSs). The most notable effort has been the large-scale multinational study that led to the development of the 2016 classification criteria for macrophage activation syndrome ...
Francesca, Minoia, Angelo, Ravelli
openaire   +2 more sources

Criteria for Cytokine Storm Syndromes

2019
In the past two decades, there has been a great deal of work aimed to devise diagnostic guidelines, classification criteria, and diagnostic scores for cytokine storm syndromes. The most notable effort has been the large-scale multinational study that led to the development of the 2016 classification criteria for macrophage activation syndrome (MAS ...
Francesca Minoia   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy